From: ROS attenuates TET2-dependent ZO-1 epigenetic expression in cerebral vascular endothelial cells
Group | Age | Gender | Cause of death | Post mortem interval (h) | Neuropathology |
---|---|---|---|---|---|
Aged | 66 | Male | Lobular pneumonia | 40 | None |
98 | Female | Lobular pneumonia | 36 | None | |
66 | Male | Pulmonary thromboembolism | 72 | None | |
90 | Female | Multiple organ dysfunction syndrome | 36 | None | |
83 | Male | Lobular pneumonia | 48 | None | |
88 | Female | Cachexia | 24 | None | |
74 | Female | Lobular pneumonia | 32 | Mild edema | |
89 | Female | Cachexia | 36 | none | |
Adult | 29 | Female | Septic shock | 56 | Mild edema |
28 | Male | Acute complete intestinal obstruction | 70 | Mild edema | |
40 | Female | pulmonary thromboembolism | 50 | None | |
52 | Male | Lobular pneumonia | 38 | None | |
54 | Female | Respiratory tract obstruction | 20 | None | |
 | 52 | Male | Heart failure | 36 | None |
 | 54 | Female | Asphyxia | 24 | None |
 | 58 | Female | Cachexia | 24 | None |